ConductScience.org, home

Paper33431024

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.

Jarada TN and 2 others. J Cheminform, 2020. Cited by 215 papers, by iCite.

Cite this record

ConductScience Library. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. Papers, record 33431024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33431024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions.
PubMed
Journal
J Cheminform
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
215
iCite
Relative citation ratio, by iCite
12.1
iCite
Revised in PubMed
2024-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jarada TNTamer N
2Rokne JGJon G
3Alhajj RRedahttps://orcid.org/0000-0001-6657-9738

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References137

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127354693A probabilistic approach for collective similarity-based drug-drug interaction prediction.Bioinformatics2016https://conductscience.org/library/papers/27354693PubMed
215286734Drug repositioning: identifying and developing new uses for existing drugs.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15286734PubMed
331874614Predicting drug-target interactions from drug structure and protein sequence using novel convolutional neural networks.BMC Bioinformatics2019https://conductscience.org/library/papers/31874614PubMed
432409766Dozens of coronavirus drugs are in development - what happens next?Nature2020https://conductscience.org/library/papers/32409766PubMed
521654673PREDICT: a method for inferring novel drug indications with application to personalized medicine.Mol Syst Biol2011https://conductscience.org/library/papers/21654673PubMed
626400175PubChem Substance and Compound databases.Nucleic Acids Res2016https://conductscience.org/library/papers/26400175PubMed
722859915Assessing drug target association using semantic linked data.PLoS Comput Biol2012https://conductscience.org/library/papers/22859915PubMed
830364956HMDD v3.0: a database for experimentally supported human microRNA-disease associations.Nucleic Acids Res2019https://conductscience.org/library/papers/30364956PubMed
923376192Pharmaco-miR: linking microRNAs and drug effects.Brief Bioinform2014https://conductscience.org/library/papers/23376192PubMed
1019881490Predicting new molecular targets for known drugs.Nature2009https://conductscience.org/library/papers/19881490PubMed
1125264495A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity.Proceedings (IEEE Int Conf Bioinformatics Biomed)2012https://conductscience.org/library/papers/25264495PubMed
1224297544Exploring the pharmacogenomics knowledge base (PharmGKB) for repositioning breast cancer drugs by leveraging Web ontology language (OWL) and cheminformatics approaches.Pac Symp Biocomput2014https://conductscience.org/library/papers/24297544PubMed
1315361058Design, implementation and management of a web-based data entry system for ClinicalTrials.gov.Stud Health Technol Inform2004https://conductscience.org/library/papers/15361058PubMed
1416381872The RCSB PDB information portal for structural genomics.Nucleic Acids Res2006https://conductscience.org/library/papers/16381872PubMed
1527678460MeSHDD: Literature-based drug-drug similarity for drug repositioning.J Am Med Inform Assoc2017https://conductscience.org/library/papers/27678460PubMed
1620142509Repositioning of an existing drug for the neglected tropical disease Onchocerciasis.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20142509PubMed
1723646105Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties.PLoS One2013https://conductscience.org/library/papers/23646105PubMed
1832393803Fast and frugal innovations in response to the COVID-19 pandemic.Nat Med2020https://conductscience.org/library/papers/32393803PubMed
1922460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012https://conductscience.org/library/papers/22460905PubMed
2021245076PubMed and beyond: a survey of web tools for searching biomedical literature.Database (Oxford)2011https://conductscience.org/library/papers/21245076PubMed

See all 137 referencesDownload CSV of references

Cited by144

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 215 citations.

PMIDTitleJournalYearIn PapersSource
42788054Robustness Analyses Substantially Narrow in silico Network-Toxicology Signals Linking Selected Pharmaceuticals and Caffeine to Vitiligo.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42788054PubMed
42509823Identification of Potential Biomarkers Associated with Impaired Fatty Acid Oxidation in Aged Skeletal Muscle Using Bioinformatics and Machine Learning Approaches.Biomolecules2026https://conductscience.org/library/papers/42509823PubMed
42422048Enhanced drug-disease association prediction through representation learning on similarity networks.Biol Methods Protoc2026https://conductscience.org/library/papers/42422048PubMed
42406005Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.Ther Innov Regul Sci2026https://conductscience.org/library/papers/42406005PubMed
42251087Systems biology-based drug repurposing for neuroinflammation treatment in activated human microglia.Sci Rep2026https://conductscience.org/library/papers/42251087PubMed
41983039molIEreVIS: exploring and interpreting the evidence behind drug repurposing predictions.Front Bioinform2026https://conductscience.org/library/papers/41983039PubMed
41959530From General-Purpose to Disease-Specific Features: Aligning LLM Embeddings on a Disease-Specific Biomedical Knowledge Graph for Drug Repurposing.bioRxiv2026https://conductscience.org/library/papers/41959530PubMed
41741490Enhanced drug disease association prediction through multimodal data integration and meta path guided global local feature fusion.Sci Rep2026https://conductscience.org/library/papers/41741490PubMed
41686791In-silico target prediction and pathway analysis of propranolol as a potential therapeutic agent for hepatocellular carcinoma.PLoS One2026https://conductscience.org/library/papers/41686791PubMed
41652023ConvAHKG: Action-based hybrid knowledge graph with a dual-channel convolutional approach for drug repurposing.Sci Rep2026https://conductscience.org/library/papers/41652023PubMed
41397027Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization.PLoS One2025https://conductscience.org/library/papers/41397027PubMed
41364066From library to landscape: integrative annotation workflows for compound libraries in drug repurposing.Database (Oxford)2025https://conductscience.org/library/papers/41364066PubMed
41210919Drug repositioning pipeline integrating community analysis in drug-drug similarity networks and automated ATC community labeling to foster molecular docking analysis.Front Bioinform2025https://conductscience.org/library/papers/41210919PubMed
41139923Dual-route embedding-aware graph neural networks for drug repositioning.Brief Bioinform2025https://conductscience.org/library/papers/41139923PubMed
41116841From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases.Adv Pharmacol Pharm Sci2025https://conductscience.org/library/papers/41116841PubMed
41088417SMPR: a structure-enhanced multimodal drug‒disease prediction model for drug repositioning and cold start.J Cheminform2025https://conductscience.org/library/papers/41088417PubMed
40841559Improving computational drug repositioning through multi-source disease similarity networks.Sci Rep2025https://conductscience.org/library/papers/40841559PubMed
40764997Drug repurposing for Alzheimer's disease using a graph-of-thoughts based large language model to infer drug-disease relationships in a comprehensive knowledge graph.BioData Min2025https://conductscience.org/library/papers/40764997PubMed
40733263Selective Cleaning Enhances Machine Learning Accuracy for Drug Repurposing: Multiscale Discovery of MDM2 Inhibitors.Molecules2025https://conductscience.org/library/papers/40733263PubMed
40674898AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia.Artif Intell Med2025https://conductscience.org/library/papers/40674898PubMed

See all 144 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HDAC13065PubTator's text mininghttps://conductscience.org/library/genes/3065NCBI Gene
TSPO706PubTator's text mininghttps://conductscience.org/library/genes/706NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33431024

GET https://conductscience.org/api/papers/v1/33431024/references?page=2